vs. non-LAD lesions (-12.07% vs. -8.07%, p Ͻ .0001). The highest ED (-12.05%, pϽ.001) was in 3.0 mm DES. ED correlated with plaque burden for Endeavor (r ϭ -0.267, pϽ0.001) and Xience (r ϭ -0.17, pϽ.01), but not Resolute (r ϭ 0.006, pϭ0.92).
left main coronary artery stenosis. This study aimed to compare OCT to IVUS performance to assess immediate results after left main percutaneous coronary intervention (PCI) and to detect complications after left main stenting. Methods: Patients with unprotected left main stenosis refered for PCI because of high risk surgery or low syntax score were included at our centre. T provisional stenting with last generation drug eluting stent was the predefined planned strategy. OCT and IVUS analysis were performed immediately after PCI for each patients in the main branch. Additional procedures (balloon inflation, second stent) was left at the discretion of the operator, depending of OCT and IVUS results. Images from OCT and IVUS were analyzed by 2 operators to look at stent expansion, stent apposition and vessel dissection. Results: 15 patients were finally included. OCT and IVUS was successfully performed without any specific complication. A stent underexpansion was found in 3 patients and no difference between IVUS and OCT efficiency was found for this criteria. For one patient, a vessel dissection at the distal edge of the stent was observed by OCT but not by IVUS. Concerning stent apposition, a circumferential stent malapposition was found in 4 patients by OCT at the proximal part of the stent and was not seen by IVUS. Local malappositions were also found in 3 patients by OCT compared to only one confirmed by IVUS. Conclusions: This pilot study for the use of OCT in left main stenting showed that this technique is highly feasible in this situation. Our results suggest that OCT may be more accurate than IVUS for dissection and malapposition diagnosis. Background: Though efficacy of everolimus-eluting stent (EES; Xience V) is wellestablished by many clinical evidences, several trials failed to show superiority in diabetic subset. We hypothesized that inappropriate stent expansion in complex lesion of diabetes due to thin cobalt chromium platform may be one of the reasons. The purpose of this study is to investigate this hypothesis using intravascular ultrasound (IVUS). Methods: 183 de novo lesions (62 EES, 69 paclitaxel-eluting stent (PES; Taxus Express2, thick stainless platform) and 52 biolimus-eluting stent (BES; Nobori, thick stainless platform with open cell design)) treated by elective IVUS-guided PCI for stable patients were recruited in this study. Stent size was determined according to preprocedural IVUS findings. After stent deployment, IVUS procedure was repeated and stent diameter and cross-sectional area (CSA) were measured. If stent expansion was inadequate, post dilation was performed using short-length high pressure balloon and again IVUS was performed. IVUS findings were then compared with estimated diameter and CSA calculated from each stent compliance chart. Results: In EES, there were significant differences of stent expansion and symmetry index between diabetic and non-diabetic just after stenting. These differences were not observed in thick stainless platform PES and BES though stent designs were different between two stents. According to IVUS, 68% of diabetic cases in EES group required post balloon dilatation to obtain optimal stent expansion. After post dilatation, difference between diabetic and non-diabetic disappeared in EES. Conclusions: In EES, asymmetrical stent underexpansion was observed in diabetic patient after stent deployment, however, IVUS-guided post-dilatation overcome this disadvantage. IVUS-guided EES implantation can improve clinical outcome in patients with diabetes. 
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